SBI Securities’s Senti Biosciences Holdings SNTI Stock Holding History

SBI Securities’s Portfolio SNTI Stock Details SNTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$367	Hold	334	–	–	﹤0.01%	3142
2026 Q1	$271	Sell	334 -2	-0.6%	-$2	﹤0.01%	3108
2025 Q4	$349	Hold	336	–	–	﹤0.01%	3006
2025 Q3	$474	Sell	336 -2	-0.6%	-$3	﹤0.01%	2992
2025 Q2	$713	Hold	338	–	–	﹤0.01%	2821
2025 Q1	$1.14K	Buy	338 +1	+0.3%	+$4	﹤0.01%	2527
2024 Q4	$1.18K	Buy	+337	New	+$1.08K	﹤0.01%	2536

Other funds holding SNTI

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

MVM

Menlo Ventures Management Menlo Park, California $357M AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SBI Securities's SNTI Position: Q2 2026 in Review

SBI Securities held its Senti Biosciences Holdings (SNTI) position steady in Q2 2026 at 334 shares worth $367. The position accounts for ﹤0.01% of the portfolio, ranked #3142.

SBI Securities first reported a position in SNTI in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.18K in Q4 2024. 17 funds tracked by Wall St. Rank hold SNTI as of Q2 2026.

SBI Securities held 334 shares of Senti Biosciences Holdings worth $367 as of Q2 2026.
SBI Securities left its Senti Biosciences Holdings share count unchanged in Q2 2026.
Senti Biosciences Holdings made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3142 holding.
SBI Securities first reported a position in Senti Biosciences Holdings in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Senti Biosciences Holdings position peaked at $1.18K in Q4 2024.
17 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.